Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > 57,000 views, THTX YouTube video link below

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Sep 27, 2022 9:51am

111 Views

Post# 34989045

RE:RE:RE:RE:RE:RE:57,000 views, THTX YouTube video link below

The old line that there is no such thing as bad publicity certainly applies in this case.

My guess about how this came about is the ZipTrader guy need content for his YouTube show. I am not sure what his business model might be but would I be surprised if he positioned his personal portfolio in a small cap stock that can be easily moved by his followers and then touts it to them? No, I would not be surprised. He just needs a "hook" - in this case the upcoming approval of IV Push and he can talk nonsense around that. The followers buy, he sells and he makes a living for himself. The cost of doing business is hair gel, brightly colored suits and few minor colorful props.